Care of the adolescent with HIV

Clinical Obstetrics and Gynecology

Volumn 51, Issue 2, 2008, Pages 319-328

  Henry Reid, Lisa M ^a   Martinez, Jaime ^a  

^a Stroger Hospital   (United States)

Author keywords

Adolescent; AIDS; Antiretroviral therapy (ARV); HIV; Maternal to child transmission (MCTC); Sexually transmitted infection

Indexed keywords

BIOLOGY; CONFIDENTIALITY; CONTRACEPTION; COUNSELING; GYNECOLOGY; HEALTH CARE; HUMAN IMMUNODEFICIENCY VIRUS; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; IMMUNE SYSTEM; KNOWLEDGE; OBSTETRICS; PREGNANCY; PRENATAL CARE; REPRODUCTIVE HEALTH; REVIEW; RISK FACTOR; VAGINITIS;

ACQUIRED IMMUNODEFICIENCY SYNDROME; ADOLESCENT; ADULT; CHILD; COUNSELING; DISEASE TRANSMISSION, VERTICAL; FEMALE; GYNECOLOGY; HIV INFECTIONS; HUMANS; MASS SCREENING; OBSTETRICS; PREGNANCY; PREGNANCY COMPLICATIONS, INFECTIOUS; PREGNANCY IN ADOLESCENCE; RISK FACTORS; RISK-TAKING; UNITED STATES;

EID: 43249123007     PISSN: 00099201     EISSN: None     Source Type: Journal    
DOI: 10.1097/GRF.0b013e31816d740c     Document Type: Review

References (50)

1. UNAIDS Epidemic Update. December 2005.
2. UNAIDS, Report on the Global HIV/AIDS Epidemic, July 2002.
3. CDC. HIV/AIDS Surveillance Report, 2005. Atlanta, GA; 2006.
4. Centers for Disease Control and Prevention. HIV/AIDS Surveillance Report 2002;14.
5. Anderson RN. CDC, HIV/AIDS Fact Sheet: HIV/AIDS among women. 2007.
6. CDC, Slide Set: HIV/AIDS Surveillance in Adolescents and Young Adults (through 2005).
7. Amaro H. Love, sex, and power: considering women's realities in HIV prevention. Am Psychol. 1995;50:437-447.
8. Harper GW. Contextual factors that perpetuate statutory rape: the influence of gender roles, sexual socialization, and sociocultural factors. DePaul Law Review. 2001;50:301-322.
9. O'Brien TR, George J, Epstein S, et al. Testing for antibodies to human immunodeficiency virus type 2 in the United States. MMWR. 1992;41:1-9.
10. MMWR December 19, 1992/41, 1993 Revised Classification System for HIV Infection and Expanded Surveillance Case Definition for AIDS Among Adolescents and Adults www.cdc.gov/MMWR.
11. CDC. 1993 Revised Classification System for HIV Infection and Expanded Surveillance Case Definition for AIDS Among Adolescents and Adults. MMWR 1992;44(RR-17).
12. Lifson AR, Rutherford TW, Jaffee HW. The natural history of human immune deficiency virus infection. J Infect Dis. 1988;158:130-167.
13. Glynn MK, Rhodes P. Estimated HIV prevalence in the United States at the end of 2003. Presentation, National HIV Prevention Conference; June 2005.
14. MMWR Recommendations and Reports September 22, 2006/55(RR14); 1-17 Revised Recommendations for HIV testing of Adults, Adolescents and Pregnant Women in Health-Care Settings.
15. Smith DK, Groshskopf LA, Black RJ, et al. Antiretroviral postexposure prophylaxis after sexual, injection-drug use, or other nonoccupational exposure to HIV in the United States. MMWR. 2005;54:1-20.
16. Schwebke JR. Abnormal vaginal flora as a biologic risk factor for acquisition of HIV infection and Sexually transmitted Diseases. J Infect Dis. 2005;192:1315-1317.
17. Sweet RL. Gynecologic conditions and bacterial Vaginosis: implications for the non-pregnant patient. Infect Dis Obstet Gynecol. 2000;8:184-190.
18. Varghese B, Maher JE, Peterman TA, et al. Reducing the risk of sexual HIV transmission; quantifying the per-act risk for HIV on the basis of choice of partner, sex act, and condom use. Sex Transm Dis. 2002;29:38-43.
19. Cooper ER, Charuarat M, Mofenson L, et al. Combination antiretroviral strategies for the treatment of pregnant HIV-1 infected women and prevention of perinatal HIV-1 transmission. AIDS. 2002;29:484-494.
20. Kahn JO, Walker BD. Acute human immunodeficiency virus type1 infection. N Engl J Med. 1998;339:33.
21. Hecht FM, Busch MP, Rawal B, et al. Use of laboratory tests and clinical symptoms for identification of primary HIV infection. AIDS. 2002;16:1119-1129.
22. Altfeld M, Rosenberg ES, Shankarappa R, et al. Cellular immune responses and viral diversity in individuals treated during acute and early HIV-1 infection. J Exp Med. 2001;193:169-180.
23. Lichterfeld M, Kaufmann DE, Yu XG, et al. Loss of HIV-1 specific CD8+ T cell proliferation after acute HIV-1 infection and restoration by vaccine-induced HIV-1 specific CD4+ T Cells. J Exp Med. 2004;200:701-712.
24. Rich JD, Merriman NA, Mylonakis E, et al. Misdiagnosis of HIV infection by HIV-1plasma viral load testing: a case series. Ann Intern Med. 1999;130:37-39.
25. Pilcher CD, Foust E, Ashby R, et al. Sexual transmission risk and rapid public health intervention in acute HIV infection. Program and abstracts of the 13th Conference on Retroviruses and Opportunistic Infections; February 5-8, 2006; Denver, Colorado.
26. Padian NS, Shiboski SC, Jewell NP. Female-to-male transmission of human immunodeficiency virus. JAMA. 1991;266:1664-1667.
27. Wofsy CB, Cohen JB, Hauer LB, et al. Isolation of AIDS-associated retrovirus from genital secretions of women with antibodies to the virus. Lancet. 1986;1:527-529.
28. Weinstock H, Berman S, Cates W Jr. Sexually transmitted diseases among American youth; incidence and prevalence estimates, 2000. Perspect Sex Reprod Health. 2004;36:6-10.
29. Burstein GR, Gaydos CA, Diener-West M, et al. Incident Chlamydia trachomatis infections among inner-city adolescent females. JAMA. 1998;28:521.
30. Centers for Disease Control and Prevention Revised Guidelines for HIV Counseling, Testing, and Referral and Revised Recommendations for HIV Screening of Pregnant Women. MMWR. 2001-1:50 (No. RR-19).
31. Sill A, Kreisel K, Deeds BG, et al. Adolescent trials network for HIV/AIDS interventions. Calibration and validation of an oral fluid-based sensitive/less sensitive assay to distinguish recent from established HIV-1 infections. J Clin Lab Anal. 2006;21:40-45.
32. Pham T, Belzer M, Church JA, et al. Assessment of thymic activity in human immunodeficiency virus negative and positive adolescents by real-time PCR quantitation of T-cell receptor rearrangement excision circles. Clin Diagn Lab Immunol. 2003;10:323-328.
33. Douek DC, McFarland RD, Keiser PH, et al. Changes in thymic function with age and during the treatment of HIV infection. Nature. 1998;396:690-695.
34. Jamieson BD, Douek DC, Killian S, et al. Generation of functional thymocytes in the human adult. Immunity. 1999;10:569-575.
35. Flynn PM, Rudy BJ, Lindsey JC, et al. The 381 Study Team Long-Term Observation of Adolescents Initiating HAART Therapy: three-year follow-up AIDS research and human retrovirus. AIDS Res Hum Retroviruses. 2007;23:1208-1214.
36. Flynn PM, Rudy BJ, Douglas SD, et al. Virologic and immunologic outcomes after 24 weeks in HIV Type-1 infected adolescents receiving highly active antiretroviral therapy. J Infect Dis. 2004;190:271-272.
37. Cejtin HE. Gynecologic issues in HIV-infected women. Obstet Gynecol Clin N Am. 2003;30:711-729.
38. Moscicki AB, Ellenberg JH, Fahrat S, et al. Persistence of human papillomavirus infection in HIV-infected and uninfected adolescent girls: risk factor and differences by phylogenetic types. J Infect Dis. 2004;190:37-45.
39. McClelland RS, Wang CC, Mandaliya K, et al. Treatment of cervicitis is associated with decreased viral shedding of HIV-1. AIDS. 2001;15:105-110.
40. CDC. STD Treatment Guideline, 2006. MMWR 55(30) page 60.
41. Moodley P, Wilkinon D, Connolly C, et al. Trichomonas Vaginalis is associated with pelvic inflammatory disease in women infected with human immunodeficiency virus. Clin Infect Dis. 2002;34:519-522.
42. Sha B, Zariffard R, Wang Q, et al. Analysis of cervical vaginal lavage fluid by quantitative PCR for Gardnerella vaginalis, Mycoplasma Hominis, and Lactobacillus is a sensitive indicator of bacterial vaginosis and correlates with genital tract HIV viral load Program and abstracts of the 11th conference on Retrovirus and Opportunistic infections; February 8-11, 2004; San Francisco, California. Abstract 956.
43. Watts DH, Springer G, Minkoff H, et al. Occurrence of vaginal infections among HIV-infected and high-risk HIV-uninfected women: Longitudinal findings of the Women's Interagency HIV Study. J Acquir Immune Defic Syndr. 2006;43:161-168.
44. Mostad SB, Overbaugh J, DeVange DM, et al. Hormonal contraception, vitamin A deficiency, and other risk factors for shedding of HIV-1 infected cells from the cervix and vagina. Lancet. 1997;350:922-927.
45. Wang CC, McClelland RS, Overbaugh J, et al. The effect of hormonal contraception on genital tract shedding of HIV-1. AIDS. 2004;18:205-209.
46. Prakash M, Patterson S, Gotch F, et al. Ex vivo analysis of HIV-1 co-receptors at the endocervical mucosa of women using oral contraceptives. BJOG. 2004;111:1468-1470.
47. Lavreys L, Chohan V, Overbaugh J, et al. Hormonal contraception and risk of cervical infections among HIV-1 seropositive Kenyan women. AIDS. 2004;18:2179-2184.
48. U.S. Department of Health and Human Services. Guidelines for the Use of Antiretroviral Agents in HIV-1 Infected Adults and Adolescents. October 10, 2006 - online aidsinfo.nih.gov/GuidelineDetail.aspx?GuidelineID = 7.
49. Levin L, Henry-Reid L, Murphy DA, et al., and the Adolescent Medicine HIV/AIDS Research Network. Incident pregnancy rates in HIV infected and HIV uninfected at risk adolescents. J Adolesc Health. 2001;29S:101-108.
50. Brogly SB, Watts DH, Ylitalo N, et al. Reproductive health of adolescent girls perinatally infected with HIV. Am J Public Health. 2007;97:1047-1052.